Major diabetes, cardiac drugs to cost 35% less
July 15, 2014 10:08 ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has sought to control the prices widely-used and expensive 50 drug formulations which are used to treat diabetes and cardiac disorders. The order, which benefits millions of